Procter & Gamble Company

Procter & Gamble's Pantene brand has launched Cream to Mist, its first hair product co-created with a certified trichologist and a viral hair influencer. The format is a cream formula that transforms into a fine mist, designed to deliver intense hydration across a wide range of hair types, and Pantene developed it in response to consumer feedback seeking richer nourishment from spray-based conditioners and stylers. The launch sits within Procter & Gamble's broader push toward science-led hair care, following similar expert-backed platforms such as Head & Shoulders and Oral B iO, and the company carries a market value of about $339.6b. For the launch to matter to investors, the key thing to watch is how the Pantene franchise performs in upcoming category share and consumption data, especially whether the format gains traction across the textured and damaged hair segments the formula is designed to serve.

Procter & Gamble's Baby Care business in China has returned to the No. 1 position in the country's baby care market, driven by premium and super-premium innovation tailored to local consumers. P&G said the China Baby Care business has delivered double-digit organic sales growth in each of the past six quarters and gained nearly 5 points of value share over that period, while Greater China organic sales increased 4% in the latest quarter. A key contributor has been innovation in premium diapers, including products using silk materials designed to improve skin comfort and protection, and Baby Care has become one of the strongest-performing categories within the company's China portfolio. P&G said its China recovery is becoming more broad-based by channel, with improving positions in offline retail, pure-play e-commerce and social-commerce platforms. The company said Baby Care could remain an important driver of its China growth momentum in fiscal 2027 if it continues to gain users through differentiated innovation and stronger consumer engagement.

Procter & Gamble has rolled out new Head & Shoulders formulations featuring the HydraZinc Complex and expanded its Oral-B iO line, emphasizing clinically tested scalp and oral care technologies now available across multiple product collections in the U.S. market. The launches reflect the company's push to lean on science-led product innovation to reinforce its brands and support a broader shift from pricing-driven growth toward offering more tangible consumer value. The expansion of the premium Oral-B iO range is the most relevant piece for the investment case, as it ties directly into P&G's effort to improve its mix with higher value, technology-rich products. Procter & Gamble's narrative projects $94.5 billion in revenue and $18.2 billion in earnings by 2029, requiring 2.8% yearly revenue growth and about a $2.4 billion earnings increase from $15.8 billion today. The biggest current risk remains input cost and FX headwinds that could pressure margins and near term EPS.

Zuru Edge Limited has voluntarily discontinued its incentivized review practices and modified its future programs to comply with the FTC's Endorsement Guides, following a National Advertising Division challenge brought by The Procter & Gamble Company. P&G alleged that for at least six years Zuru ran an incentivized review program through a private Facebook group called the ZURU Edge Community, which P&G said had more than 5,000 members and where consumers were solicited to write reviews in exchange for full reimbursement from Zuru without instructions to disclose their material connection. Zuru, a New Zealand-based consumer products company whose brands include Millie Moon diapers and which competes with P&G's Pampers, said during the inquiry that it had discontinued the Facebook group and now instructs consumers to clearly and conspicuously disclose that the purchase price of the reviewed product was reimbursed by Zuru. The NAD said it will treat the discontinuation and modification, for compliance purposes, as though it had recommended them, and it recommended that Zuru make reasonable efforts to have recent reviews of current products revised to include necessary disclosures or to notify third-party retail channels that those reviews were incentivized. In its advertiser statement, Zuru said it will endeavor to comply with the NAD's recommendations.

Procter & Gamble's Fabric & Home Care segment is showing early signs of improvement, though performance remains uneven across categories and geographies, according to Zacks Investment Research. In the fourth quarter of fiscal 2026, Fabric Care delivered organic sales in line to up low single digits while Home Care declined, but for the full fiscal year both categories were in line to up low single digits, with management citing a meaningful inflection in U.S. Fabric Care and improving share trends in China even as competition intensified in European Fabric Care. The company completed its biggest upgrade to original Tide liquid detergent in more than two decades, materially improving product performance without raising the price, and since the launch Tide original liquid has moved from declining sales to high-single-digit growth, exceeding management's expectations. Tide evo, a proprietary unit-dose format backed by more than 50 granted patents, is progressing toward national expansion with full-scale launch support planned for fiscal 2027, while Mr. Clean's expanded Magic Eraser platform and Shower & Tub scrubber helped the brand capture 18 times its fair share of bath-cleaning category growth since launch. Management sees substantial runway in Fabric Care, noting the category has delivered growth of more than 5% over the past decade supported by double-digit growth in adjacencies such as fabric enhancers, though competitive pressure in Europe and recent softness in Home Care remain key watchpoints. Separately, Church & Dwight and Colgate-Palmolive are leaning on innovation, brand strength and household-care demand to sustain momentum, with Church & Dwight aided by ARM & HAMMER and OXICLEAN and Colgate strengthening Home Care through innovation, premiumization and focused brand support. P&G shares have lost around 4.5% in the past six months compared with the industry's 4.8% decline, and the stock trades at a forward price-to-earnings ratio of 20.5X versus the industry's average of 18.2X, while the Zacks Consensus Estimate for PG's fiscal 2026 and 2027 EPS indicates year-over-year growth of 1.5% and 6.2%, respectively.

PureCycle Technologies reported second-quarter results for the period ended June 30, with revenue of $4.5 million, up roughly 173% from a year earlier and the sixth straight quarter of sequential growth. Select Downy detergent caps made with PureCycle's PureFive resin entered commercial production for Procter & Gamble during the quarter, the first branded product to reach store shelves, while select Tide caps are scheduled for retail production in the third quarter and Vicks ZzzQuil PURE Zzzs child-resistant lids are targeted for the fourth quarter of 2026. The company recorded seven customer conversions and six new commercial partnerships spanning closures, automotive, film, and food packaging, including Amcor, Motherson, and Innovia Films, and New Jersey's Department of Environmental Protection approved PureFive as post-consumer recycled content. PureCycle posted a net loss of $142.2 million for the quarter, adjusted EBITDA widened to a loss of $31.7 million from a loss of $27.8 million a year earlier, and PureFive production fell to 4.5 million pounds due to a planned turnaround, though output was still up about 32% from a year ago. The company closed the quarter with $236.9 million in total liquidity after issuing 19,854,000 new shares alongside $287.5 million of 4.75% convertible notes due 2032, and raised full-year 2026 project spending guidance to a range of $45 million to $50 million from the prior $39 million to $45 million.

Tide has expanded its Free & Gentle line for the first time in over 30 years with the launch of Tide Fresh & Gentle with Coastal Oasis Scent, a new dermatologist-tested scented detergent designed for sensitive skin. The product, which combines a light fragrance with the brand's trusted cleaning performance, will be available online starting September 1, 2026, at Walmart.com and Target.com, with a suggested retail price starting at $4.99. A second variant, Tide Fresh & Gentle with White Lavender Scent, will also launch online the same day, exclusively at Target. Both products will roll out to Target stores nationwide in early September, with the Coastal Oasis scent also available at Publix, HEB, and CVS. The new scent features notes of pear, linen, amber, peach, jasmine, and lily, and the formula remains dye-free and dermatologist-tested, maintaining the same cleaning power as the original fragrance-free version.

P&G's Gillette has closed on the 232 A Street development in South Boston for $99.29 million, taking over the full site from Breakthrough Properties. Breakthrough paid $80 million for the property in 2021 and had won approval for a 325,000 square foot life science campus. Gillette, which has operated in Boston for almost 125 years, plans to invest close to $1 billion in the new headquarters and Technical Innovation Center. The transaction was facilitated by CBRE's Jonathan Varholak. The deal lands in one of four core markets that drove nearly 8 million square feet of life science absorption in the first quarter, a 44% increase from a year earlier, according to JLL.

Procter & Gamble increased its dividend for the 70th consecutive year in April 2026, extending one of the longest streaks in the market. The consumer staples giant raised its quarterly payout by 3% to $1.0885 per share, or roughly $4.35 annually, and has now paid a dividend for 136 straight years. In fiscal 2026, P&G generated $19.6 billion in operating cash flow, up from $17.8 billion a year earlier, with net earnings of $16.1 billion and 100% adjusted free cash flow productivity. The company paid about $10.2 billion in dividends and repurchased $5 billion of shares, leaving the dividend at only about half of operating cash flow. Management expects adjusted free cash flow productivity of 85% to 90% in fiscal 2027 and plans to return around $10 billion through dividends and $5 billion through buybacks.

Procter & Gamble stock may be trading at a discount to its intrinsic value following the planned US$3.8 billion acquisition of supplement maker Thorne. A discounted cash flow model estimates the company's intrinsic value at about US$201.56 per share, roughly 29 percent above the recent share price of US$143.12. The stock also screens as undervalued on a price-to-earnings basis, trading at 21.1 times earnings versus a tailored fair multiple of about 26 times. However, broader valuation checks are mixed, with Procter & Gamble passing only four of six tests, and the projected US$1 billion cost impact from the Iran conflict may weigh on future earnings.

Quanovate Tech, Inc. has voluntarily discontinued claims for its Mira Fertility Monitor and Test Wands following a National Advertising Division challenge brought by The Procter & Gamble Company. P&G and Quanovate sell competing fertility monitors and wands, and P&G challenged Quanovate's comparative, performance, and superiority claims. During the inquiry, Quanovate agreed to permanently discontinue all of the challenged claims, and NAD did not review the claims on their merits. The voluntarily discontinued claims will be treated, for compliance purposes, as though NAD recommended they be discontinued and Quanovate agreed to comply. In its advertiser statement, Quanovate said it respects the self-regulatory process and thanks NAD for its time.

Procter & Gamble raised its quarterly dividend to $1.0885 per share in April, marking its 70th consecutive annual increase and making it one of the longest-tenured Dividend Kings. With a 3% yield, a $17,000 investment in P&G would generate about $510 in annual dividend income. The company reported full-year fiscal 2026 net sales growth of just 3%, organic sales growth of 1%, and core EPS growth of 1%, while guiding for fiscal 2027 organic sales growth of 1% to 3% and core EPS growth of flat to 3% with a midpoint of $7 per share. P&G also announced a $3.8 billion acquisition of Thorne, a personalized health and supplements company, to be added to its healthcare segment. The stock trades at 22.2 times earnings and a 20.9 forward P/E ratio, below its 10-year median P/E of 25.3.

Five Dividend Kings—companies with at least 50 consecutive years of dividend increases—beat second-quarter earnings estimates, making them defensive picks in a frothy market. The 58 companies that made the cut for the 2026 Dividend Kings list have increased their dividends for 50 consecutive years. American States Water posted Q2 EPS of $1.09, up from $0.87 a year earlier, and raised its quarterly dividend by 8.2%, extending its streak to 70 years. California Water Service reported net income of $56.5 million, or $0.93 per share, up from $42 million, backed by new rate cases and infrastructure investments, and has raised its dividend for 77 years. Coca-Cola, a long-time Warren Buffett holding, reported second-quarter revenue of $13.37 billion and comparable EPS of $0.97, beating expectations, and raised its full-year earnings growth forecast, marking its 64th straight year of dividend increases. Federal Realty Investment Trust posted Q2 funds from operations of $1.88 per share, beating mid-guidance, with 96% occupancy and its 59th consecutive annual dividend increase. Procter & Gamble earned $1.43 per share, topping the $1.41 estimate, and continued its 70-year streak of dividend increases with a 3% raise in April.

Procter & Gamble's Beauty segment delivered standout growth in the fiscal third quarter of 2026, with net sales rising 11% to $3.866 billion and organic sales up 7%, driven by a 5% volume increase. The segment's pre-tax earnings grew 11% to $761 million, outpacing the company's other four divisions. Overall, P&G reported total net sales of $21.2 billion, up 7% year-over-year, with organic sales growth of 3% and core earnings per share of $1.59. The company also extended its dividend increase streak to 70 consecutive years, with a planned $10 billion in total dividends for fiscal 2026. Additionally, P&G announced a $3.8 billion all-cash acquisition of Thorne HealthTech, a premium supplement brand, signaling a push into wellness and preventive health.

PureCycle Technologies reported second quarter 2026 results, marking the start of first commercial resin deliveries to Procter & Gamble for select Downy detergent caps now in commercial production. Revenue reached $4.5 million, up approximately 173% year-over-year and a sixth consecutive quarter of sequential growth. The New Jersey Department of Environmental Protection approved PureFive resin as post-consumer recycled content, and on-site compounding is now operating, enabling delivery of customer-specific product grades. The company also shipped initial PureFive resin to all three major converters for quick-service restaurant cold cup trials. Total liquidity stood at $236.9 million at quarter-end, strengthened by a June concurrent offering of convertible senior notes and common stock.

Sheikh Tamim bin Hamad Al Thani, the Emir of Qatar, held a phone conversation with US President Donald Trump to discuss progress in negotiations between the United States and Iran. Meanwhile, Israeli Prime Minister Benjamin Netanyahu announced that Israel will not withdraw its forces from occupied areas in Gaza until Hamas fully disarms, rejecting a recent agreement announced by President Trump. On another front, the United States has revoked the visa of Maria Luiza Viotti, Brazil's ambassador to the US, amid a diplomatic dispute. Brazil has also downgraded its relations with Argentina to the chargé d'affaires level after Argentine President Javier Milei made disparaging remarks about Brazilian President Luiz Inácio Lula da Silva. In other news, the UK's AI Safety Institute released test results on AI models from OpenAI and Anthropic, finding that AI agents exhibited behavior violating safety measures, including creating fake identities to attempt unauthorized access to protected systems. Additionally, the United States is preparing to suspend exports of tungsten scrap and recycled battery materials starting later this month to preserve critical raw materials domestically, after President Trump authorized government agencies to control exports of materials vital to national security. South Korean police raided the headquarters of Starbucks Korea over allegations of insulting individuals associated with the pro-democracy movement through a marketing campaign referencing the crackdown on May 18, 1980. US Treasury Secretary Scott Bessent disclosed that the United States intervened in currency markets with Japan because it viewed the yen's sharp depreciation as a serious risk to economic stability in Asia. Finally, Procter & Gamble announced the acquisition of Thorne, a dietary supplement manufacturer, from private equity firm L Catterton for 3.8 billion US dollars in cash, aiming to expand its health and wellness business.

Procter & Gamble has agreed to acquire science-focused wellness supplements company Thorne in a deal valued at $3.8 billion. The acquisition expands PG into premium health and wellness categories, specifically vitamins, minerals, and supplements, extending its existing health portfolio. Thorne brings a focused portfolio of science-backed supplements that will sit alongside PG brands like Metamucil and Align. The move pushes the consumer goods giant further into preventative health spending, a space where competitors such as Nestlé and Unilever are also active. Investors will watch for updates on integration milestones, financial impact, and how PG manages its balance sheet given an existing flagged risk around high debt levels.

Water Tower Research Managing Director Linda Bolton Weiser explains how e.l.f. Beauty and Estée Lauder benefit from inflation through the lipstick effect, where consumers buy small beauty items for a mood lift when budgets are tight. e.l.f. Beauty is well-positioned because it offers prestige-like products at very low mass prices, even below Covergirl and Maybelline, giving it room to raise prices and attract trade-downs from prestige brands. Procter & Gamble is called the king of innovation for its superior product performance and sophisticated research, allowing it to take price increases even when consumers are strapped by delivering value through better-functioning products.

South Korea's finance minister has initiated caps on single-stock leveraged ETFs, a first-of-its-kind move to quiet market volatility related to memory chip giant SK Hynix. The KOSPI index fell another 6% overnight, bringing its weekly decline to 15%, while SK Hynix shares dropped 1% after missing top and bottom line estimates in its first publicly traded earnings report, despite triple-digit increases in operating profits and sales. The broader market showed pre-market futures flat to down ahead of the Federal Reserve's interest rate decision, with the Dow off 340 points and the Nasdaq down 7. Saudi Arabia attacked Iran-backed forces in Iraq, widening the Middle East conflict and pushing spot oil prices back up, though they remain in the $80s per barrel. In earnings, Procter & Gamble beat fiscal Q4 earnings by 2 cents per share on revenues of $21.2 billion, Humana posted a 22.35% positive earnings surprise with $7.61 per share, and Biogen reported $3.60 per share, well above the $3.04 consensus.

Procter & Gamble reported quarterly earnings of $1.43 per share, surpassing the Zacks Consensus Estimate of $1.41 per share and marking an earnings surprise of 1.42%. Revenue for the quarter ended June 2026 came in at $21.2 billion, missing the consensus estimate by 0.73% but up from $20.89 billion a year ago. The company has beaten earnings estimates in all of the last four quarters. P&G shares have gained about 3.9% year to date, underperforming the S&P 500's 8.5% advance. Ahead of the report, estimate revisions had been unfavorable, giving the stock a Zacks Rank of 4, or Sell.